A Study on the Status and Genetic Characteristics of Carbapenem Resistance of Clinical-derived Bacteria in Northern Gyeonggi Province-Reference-Cited by-同舟云学术

A Study on the Status and Genetic Characteristics of Carbapenem Resistance of Clinical-derived Bacteria in Northern Gyeonggi Province

Published:2023-12-31 Issue:2 Volume:28 Page:226-232
ISSN:2671-9886
Container-title:Korean Journal of Healthcare-Associated Infection Control and Prevention
language:en
Short-container-title:Korean J healthc assoc Infect Control Prev

Author:

Lee Chan-mi¹^ORCID,Kim Kyung-A¹,Oh Sang-Heon¹,Jang Mi-Jung¹,You Su-Hyun¹,Park Han-Byeol¹,Ko Da-Jung¹,Kweon Bo-yeon¹

Affiliation:

1. Microbiological Inspection Team in North Branch, Gyeonggi Province Institute of Health and Environment, Uijeongbu, Korea

Publisher

Korean Society for Healthcare-associated Infection Control and Prevention

Subject

General Medicine

Link

https://pdf.medrang.co.kr/KJICP/2023/028/KJICP028-02-226.pdf

Reference10 articles.

1. Korea Disease Control. Carbapenem-resistant Enterobacteriaceae (CRE). https://npt.kdca.go.kr/npt/biz/npp/portal/nppSumryMain.do?icdCd=NB0020&icdgrpCd=02&icdSubgrpCd= ((Updated on 10 September 2020)).

2. Park SY. Infection and management of carbapenem-resistant intestinal bacteria. Busan, Korea;2019. p. 249-51.

3. Park JW, Lee EJ, Lee SJ, Lee HM. Status of carbapenemase-producing Enterobacteriaceae incidences in Korea, 2015-2016. Public Health Wkly Rep 2017;10:1243-7.

4. Korea Center for Disease Control & Prevention. Infection control guidelines for multidrug resistant microorganisms in healthcare facilities. Cheongju; Korea Center for Disease Control & Prevention, 2012:17.

5. Korea Disease Control and Prevention Agency. Guidelines for management of infectious diseases 2022. Cheongju; Korea Disease Control and Prevention Agency, 2022:56-7.